Polymorphism of TP53 (rs1042522) gene and peculiarities of the immune profile in children exposed to airborne benzo(a)pyrene

View or download the full article:

health-risk-analysis-2024-1-15.pdf

UDC:

614.72: 547.681

DOI:

10.21668/health.risk/2024.1.15.eng

Authors:

О.V. Dolgikh, N.А. Nikonoshina

Organization:

Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya St., Perm, 614045, Russian Federation

Abstract:

Examining peculiarities of an immune profile and genetic polymorphisms is especially relevant when identifying markers of effect and sensitivity to exposure to benzo(a)pyrene in northern areas.
We examined 1253 children who lived in industrial centers and on conditionally clean territories in the north and south of Eastern Siberia. Levels of benzo(a)pyrene in ambient air and in children’s blood were determined by using HPLC. TP53 (rs1042522) polymorphism was examined by using real-time PCR; p53 levels were identified with flow cytofluorometry; IgG to benzo(a)pyrene, by the radioallergosorbent tests.

Exposure of children in Northern Siberia to airborne benzo(a)pyrene at the dose of 7.11•10-3 µg/(kg•day) causes ben-zo(a)pyrene contamination in blood, activates apoptosis (p53) and stimulates occurrence of specific sensitization (IgG to benzo(a)pyrene) (p < 0.05). Similar disorders were established in children in Southern Siberia under exposure to airborne benzo(a)pyrene at the dose of 86.46•10-3 µg/(kg•day). The detected changes in immune profiles of children living in Northern Siberia are associated with G-allele and GG-genotype (rs1042522) of the TP53 gene (OR = 1.37–1.83, p < 0.05); children in Southern Siberia, С-allele and СС-genotype of the said gene (OR = 1.55–2.38, p < 0.05).

Therefore, the immune profile of children exposed to airborne benzo(a)pyrene at the dose of 7.11•10-3 µg/(kg•day) in Northern Siberia bears some signs of activated apoptosis (p53) and specific sensitization (IgG to benzo(a)pyrene) associated with G-allele and GG-genotype of the TP53 gene (rs1042522) (OR = 1.37–1.83, p < 0.05). These identified changes in the immune profile are comparable with effects produced by exposure to airborne benzo(a)pyrene at the dose of 86.46•10-3 µg/(kg•day) in Southern Siberia, which are associated with С-allele and СС-genotype of the same gene (OR = 1.55–2.38, p < 0.05). This confirms a hypothesis that effects of technogenic chemical factors can be modulated by specific climatic conditions in northern areas and a contribution made by genetic predisposition. Their combined effect creates a serious risk of developing impairments in an immune profile (OR = 1.37–1.83, p < 0.05; RR = 1.17; 95 % CI: 1.07–1.27) even under low-dose exposure to airborne benzo(a)pyrene.

Keywords:

benzo(a)pyrene, airborne exposure, children, immune profile, genetic polymorphism, apoptosis, p53, sensitization

Dolgikh О.V., Nikonoshina N.А. Polymorphism of TP53 (rs1042522) gene and peculiarities of the immune profile in children exposed to airborne benzo(a)pyrene. Health Risk Analysis, 2024, no. 1, pp. 150–157. DOI: 10.21668/health.risk/2024.1.15.eng

References:

Chang Y., Siddens L.K., Heine L.K., Sampson D.A., Yu Z., Fischer K.A., Löhr C.V., Tilton S.C. Comparative mechanisms of PAH toxicity by benzo[a]pyrene and dibenzo[def,p]chrysene in primary human bronchial epithelial cells cultured at air-liquid interface. Toxicol. Appl. Pharmacol., 2019, vol. 379, pp. 114644. DOI: 10.1016/j.taap.2019.114644
Dai Y., Xu X., Huo X., Faas M.M. Effects of polycyclic aromatic hydrocarbons (PAHs) on pregnancy, placenta, and placental trophoblasts. Ecotoxicol. Environ. Saf., 2023, vol. 262, pp. 115314. DOI: 10.1016/j.ecoenv.2023.115314
Shur P.Z., Khasanova А.А., Tsinker М.Yu., Zaitseva N.V. Methodical approaches to as-sessing public health risks under combined exposure to climatic factors and chemical air pollution caused by them. Health Risk Analysis, 2023, no. 2, pp. 58–68. DOI: 10.21668/health.risk/2023.2.05.eng
Karpin V.A., Gudkov A.B., Shuvalova O.I. Impact Analysis of Climate and Technogeneous Pressing on Residents of Northern Urban Land. Ekologiya cheloveka, 2018, vol. 25, no. 10, pp. 9–14. DOI: 10.33396/1728-0869-2018-10-9-14 (in Russian).
Zyryanov B.N., Sokolova T.F. Adaptive reactions and immunity in the newcomers of the Far North. Nauchnyi vestnik Yamalo-Nenetskogo avtonomnogo okruga, 2021, no. 2 (111), pp. 48–58. DOI: 10.26110/ARCTIC.2021.111.2.003 (in Russian).
Artemenkov A.A. Disadaptive genetic-evolutionary processes in human populations of in-dustrial cities. I.P. Pavlov Russian Medical Biological Herald, 2020, vol. 28, no. 2, pp. 234–248. DOI: 10.23888/PAVLOVJ2020282234-248
Lanin D.V., Zaitseva N.V., Dolgikh O.V. Neuroendocrine mechanisms for regulation of immune system. Uspekhi sovremennoi biologii, 2011, vol. 131, no. 2, pp. 122–134 (in Russian).
Flynt E., Bisht K., Sridharan V., Ortiz M., Towfic F., Thakurta A. Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma. Cells, 2020, vol. 9, no. 2, pp. 287. DOI: 10.3390/cells9020287
Mao Y., Jiang P. The crisscross between p53 and metabolism in cancer. Acta Biochim. Bio-phys. Sin. (Shanghai), 2023, vol. 55, № 6, pp. 914–922. DOI: 10.3724/abbs.2023109
Lei F., Tian Y., Miao J., Pan L., Tong R., Zhou Y. Immunotoxicity pathway and mecha-nism of benzo[a]pyrene on hemocytes of Chlamys farreri in vitro. Fish Shellfish Immunol., 2022, vol. 124, pp. 208–218. DOI: 10.1016/j.fsi.2022.04.009
Dračínská H., Indra R., Jelínková S., Černá V., Arlt V.M., Stiborová M. Benzo[a]pyrene-Induced Genotoxicity in Rats Is Affected by Co-Exposure to Sudan I by Altering the Expression of Biotransformation Enzymes. Int. J. Mol. Sci., 2021, vol. 22, no. 15, pp. 8062. DOI: 10.3390/ijms22158062
Bukowska B., Mokra K., Michałowicz J. Benzo[a]pyrene – Environmental Occurrence, Human Exposure, and Mechanisms of Toxicity. Int. J. Mol. Sci., 2022, vol. 23, no. 11, pp. 6348. DOI: 10.3390/ijms23116348
Petrova P.G. Ecological and physiological aspects of human adaptation to the conditions of the North. Vestnik Severo-Vostochnogo federal'nogo universiteta im. M.K. Ammosova. Seriya: Meditsinskie nauki, 2019, no. 2 (15), pp. 29–38. DOI: 10.25587/SVFU.2019.2(15).31309 (in Russian).
Nikiforova V.A., Kudashkin V.A., Kiryutkin S.A. History of studying the problem of adaptation of the indigenous small peoples of the North to natural environmental conditions. Problemy sotsial'no-ekonomicheskogo razvitiya Sibiri, 2021, no. 1 (43), pp. 139–142. DOI: 10.18324/2224-1833-2021-1-139-142 (in Russian).
Pertami S.D.I., Sudiana I.K., Budhy T I., Palupi R., Arundina I. Mutant p53 Expression Of Oral Transformed Epithelium Cell In Rats Injected By Benzo[A]Pyrene. STRADA Jurnal Ilmiah Kesehatan, 2020, vol. 9, no. 1, pp. 85–92. DOI: 10.30994/sjik.v9i1.234
Nagpal I., Yuan Z.M. The Basally Expressed p53-Mediated Homeostatic Function. Front. Cell Dev. Biol., 2021, vol. 9, pp. 775312. DOI: 10.3389/fcell.2021.775312
Ounalli A., Moumni I., Mechaal A., Chakroun A., Barmat M., Rhim R.E.E., Menif S., Safra I. TP53 Gene 72 Arg/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia. Front. Oncol., 2023, vol. 13, pp. 1272876. DOI: 10.3389/fonc.2023.1272876
Dolgikh O.V., Kazakova O.A. Expression of the TР53 oncosuppressor gene modified with benzo[a]pyrene and the SARS-COV-2 vaccine antigen in an in vitro experiment. Gigiena i sanitariya, 2023, vol. 102, no. 10, pp. 1043–1047. DOI: 10.47470/0016-9900-2023-102-10-1043-1047 (in Russian).
Granowicz E.M., Jonas B.A. Targeting TP53-mutated acute myeloid leukemia: research and clinical developments. Onco Targets Ther., 2022, vol. 15, pp. 423−436. DOI: 10.2147/OTT.S265637
Ahmed S., Safwat G., Moneer M.M., El Ghareeb A.W., El Sherif A.A., Loutfy S.A. Prevalence of TP53 gene Pro72Arg (rs1042522) single nucleotide polymorphism among Egyptian breast cancer patients. Egypt. J. Med. Hum. Genet., 2023, vol. 24, pp. 24 DOI: 10.1186/s43042-023-00405-1